Aroa Biosurgery product Symphony maintains strong position with CMS proposed payment rule

Aroa Biosurgery founder and CEO Brian Ward and market access director Zack Bridges evaluated the updated payment rule proposal offered by the…

The discussion addressed why this proposal is important for the outpatient wound care market and what opportunities it could offer the product during its commercial launch process.